1 Product identity
Ingredient risk
Contains a high-risk ingredient
Chol-Less Max
BrandHoltraCeuticals→Other Combinations Capsule 10 ingredients 1 high-risk 1 caution DSLD #19374Net contents: 180 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-03-25
2 Ingredients (10)
IngredientGroupSafety
Artichoke (leaf) extractArtichoke—
PolicosanolPolicosanol—
Deodorized GarlicGarlic—
GelatinGelatin—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ High-risk ingredient — documented serious harm
Inositol — GDM prevention — 4 g/day from first trimester in high-risk women [2]
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Niacin — Conditionally Safe
⚠ Flushing at >50 mg
⚠ Hepatotoxicity at high doses
Chromium — Conditionally Safe
⚠ Hypoglycemia with diabetes meds
⚠ Rare renal/hepatic toxicity
Inositol — High risk
⚠ Flushing at >50 mg
⚠ Hepatotoxicity at high doses
Berberine — Limited Evidence
⚠ POTENT CYP INHIBITOR — many drug interactions
⚠ Hypoglycemia
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID19374
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-03-25
6 More from HoltraCeuticals
View HoltraCeuticals Safety Scorecard → 48 products
Adrenal BoostAdrenal-CalmAge WellAloe 450Antiox MaxAntiox Max7 Cite this page
Vancouver
Pkhakadze G. Chol-Less Max — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 17]. Available from: https://supplement.ge/products/dsld-19374/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG